Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion type Assertion NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_head.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion description "[miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_provenance.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion evidence source_evidence_literature NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_provenance.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion SIO_000772 24098024 NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_provenance.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion wasDerivedFrom befree-2016 NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_provenance.
- NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_assertion wasGeneratedBy ECO_0000203 NP1116521.RA2a-KQQn2AleO3Jg0_dkyNXEbxkAqQ-UvhxI-g-Ixkt0130_provenance.